Agrawal, A., Dudhedia, M., Deng, W., Shepard, K., Zhong, L., Povilaitis, E., Zimny, E., Development of tablet formulation of amorphous solid dispersions prepared by hot melt extrusion using quality by design approach. AAPS PharmSciTech 17 (2016), 214–232.
Alsenz, J., Kansy, M., High throughput solubility measurement in drug discovery and development. Adv. Drug Deliv. Rev. 59 (2007), 546–567.
Amidon, G.L., Lennernas, H., Shah, V.P., Crison, J.R., A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995), 413–420.
Baghel, S., Cathcart, H., O'Reilly, N.J., Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J. Pharm. Sci. 105:9 (2016), 2527–2544.
Bellantone, R.A., Fundamentals of amorphous systems: thermodynamic aspects. Shah, N., Sandhu, H., Choi, D.S., Chokshi, H., Malick, A.W., (eds.) Amorphous Solid Dispersions, 2014, Springer New York, 3–34.
Bruce, L.D., Shah, N.H., Waseem Malick, A., Infeld, M.H., McGinity, J.W., Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid. Eur. J. Pharm. Biopharm. 59 (2005), 85–97.
Hughey, J.R., Keen, J.M., Miller, D.A., Kolter, K., Langley, N., McGinity, J.W., The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. Eur. J. Pharm. Biopharm. 48 (2013), 758–766.
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., Onoue, S., Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int. J. Pharm. 420 (2011), 1–10.
Kolter, K., Karl, M., Gryczke, A., 2012. Hot-Melt Extrusion with BASF Pharma Polymers, 2nd ed.
Ku, M.S., Dulin, W., A biopharmaceutical classification-based right-first-time formulation approach to reduce human pharmacokinetic variability and project cycle time from first-in-human to clinical proof-of-concept. Pharm. Dev. Technol. 17 (2012), 285–302.
Lang, B., Liu, S., McGinity, J.W., Williams, R.O., Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions. Drug Dev. Ind. Pharm. 42 (2016), 429–445.
Lebrun, P., Giacoletti, K., Scherder, T., Rozet, E., Boulanger, B., A quality by design approach for longitudinal quality attributes. J. Biopharm. Stat. 25 (2015), 247–259.
Linn, M., Collnot, E.M., Djuric, D., Hempel, K., Fabian, E., Kolter, K., Lehr, C.M., Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur. J. Pharm. Biopharm. 45 (2012), 336–343.
Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46 (2001), 3–26.
Loftsson, T., Brewster, M.E., Pharmaceutical applications of cyclodextrins: basic science and product development. J. Pharm. Pharmacol. 62 (2010), 1607–1621.
Peterson, J.J., A Bayesian approach to the ICH Q8 definition of design space. J. Biopharm. Stat. 18 (2008), 959–975.
Potter, C., Tian, Y., Walker, G., McCoy, C., Hornsby, P., Donnelly, C., Jones, D.S., Andrews, G.P., Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion. Mol. Pharm. 12 (2015), 1377–1390.
Rambali, B., Verreck, G., Baert, L., Massart, D.L., Itraconazole formulation studies of the melt-extrusion process with mixture design. Drug Dev. Ind. Pharm. 29 (2003), 641–652.
Romanski, F., Zhuang, K., Langley, N., The importance of monitoring process parameters as a method for quality control for hot melt extrusion. AAPS Annual Meeting 2013, San Antonio, USA, 2013.
Sarode, A.L., Sandhu, H., Shah, N., Malick, W., Zia, H., Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation. Eur. J. Pharm. Sci. 48 (2012), 371–384.
Shah, S., Maddineni, S., Lu, J., Repka, M.A., Melt extrusion with poorly soluble drugs. Int. J. Pharm. 453 (2013), 233–252.
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L.X., Amidon, G.L., A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol. Pharm. 3 (2006), 631–643.
Thiry, J., Krier, F., Evrard, B., A review of pharmaceutical extrusion: critical process parameters and scaling-up. Int. J. Pharm. 479 (2015), 227–240.
Thiry, J., Broze, G., Pestieau, A., Tatton, A.S., Baumans, F., Damblon, C., Krier, F., Evrard, B., Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions. Eur. J. Pharm. Sc. 85 (2016), 94–105.
US Department of Health and Human Services Food and Drug Administration, 2004. Guidance for industry: PAT-a framework for innovative pharmaceutical development, manufacturing, and quality assurance.
Zhang, Y., Luo, R., Chen, Y., Ke, X., Hu, D., Han, M., Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion. AAPS PharmSciTech 15 (2014), 560–568.
Zhong, Y., Jing, G., Tian, B., Huang, H., Zhang, Y., Gou, J., Tang, X., He, H., Wang, Y., Supersaturation induced by Itraconazole/Soluplus® micelles provided high GI absorption in vivo. Asian J. Pharm. Sci. 11 (2016), 255–264.
